0
Letters |

Legislation and End-of-Life Care

F. Michael Gloth III, MD
JAMA. 2000;283(22):2933. doi:10.1001/jama.283.22.2931.
Text Size: A A A
Published online

Extract

To the Editor: Drs Orentlicher and Caplan1 described the Pain Relief Promotion Act of 1999 (PRPA) as a " . . . serious threat to palliative care." They were concerned about interference by the federal government with state authority and speculated that such legislation would inhibit good palliative care and pain relief.

I would like to share a different perspective from a hospice physician who has been active in pain promotion in Maryland where the state has passed (despite similar misleading arguments as those of Orentlicher and Caplan) legislation banning physician-assisted suicide with wording to promote good pain management,1 similar to that seen in the bill recently passed by the US House of Representatives.1 The reason that the Maryland version became law with bipartisan support (despite the fact that Maryland is arguably the most liberal state in the Union2) had to do with specific wording that provided protection for clinicians who prescribe medication for pain relief, even if such prescribing increases the risk of death or potentially hastens death. As is true with the proposed federal legislation, such prescribing would only be illegal if the physician intended to kill a patient. Even a novice prosecutor recognizes how daunting it is to prove intent.

Topics

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs